| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/01/2000 | US6020129 Stilbene synthase gene |
| 02/01/2000 | US6020127 Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy |
| 02/01/2000 | US6020123 Oligonucleotide sequences for the amplification of the genome of the retroviruses of the HIV-2 and SIV type, and their uses for in vitro diagnosis of the infections due to these viruses |
| 02/01/2000 | US6020121 Screening for an inhibitor of a global regulator of pathogenesis genes |
| 02/01/2000 | US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh. |
| 02/01/2000 | US6019980 Nucleic acid respiratory syncytial virus vaccines |
| 02/01/2000 | US6019978 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier |
| 02/01/2000 | US6019973 Vaccine against enterotoxin-induced illness. |
| 02/01/2000 | US6019972 Peptides of human T cell reactive feline protein (TRFP) |
| 02/01/2000 | US6019896 Method for using a quality metric to assess the quality of biochemical separations |
| 02/01/2000 | CA2171982C Drug binding protein |
| 02/01/2000 | CA2069085C Activatable fibrinolytic and anti-thrombotic proteins |
| 02/01/2000 | CA2047681C Vaccines for nontypable haemophilus influenzae |
| 02/01/2000 | CA2035039C Recombinant poxvirus and streptococcal m protein vaccine |
| 02/01/2000 | CA2009198C Monoclonal antibody for differentiating hiv-2 from hiv-1 seropositive individuals |
| 02/01/2000 | CA1340888C Vaccines and diagnostic assays for haemophilus influenzae |
| 01/31/2000 | CA2239259A1 Matrix attachment regions |
| 01/30/2000 | CA2244349A1 Protein fragment complementation assays for the detection of biological or drug interactions |
| 01/27/2000 | WO2000004659A2 Radio communications unit |
| 01/27/2000 | WO2000004196A2 Cis acting nucleic acid elements and methods of use |
| 01/27/2000 | WO2000004195A1 Archiving of vectors |
| 01/27/2000 | WO2000004194A1 Gene sequence variances with utility in determining the treatment of disease |
| 01/27/2000 | WO2000004190A1 Evolution of whole cells and organisms by recursive sequence recombination |
| 01/27/2000 | WO2000004186A1 Method for identifying mutants and molecules |
| 01/27/2000 | WO2000004185A1 Adenoviral based promoter assay |
| 01/27/2000 | WO2000004183A1 Bone morphogenic protein |
| 01/27/2000 | WO2000004182A1 Process and materials for production of glucosamine |
| 01/27/2000 | WO2000004179A1 Stereoselective reductive amination of ketones |
| 01/27/2000 | WO2000004178A1 Expression system containing chimeric promoters with binding sites for recombinant transcription factors |
| 01/27/2000 | WO2000004177A1 Chromatin associated proteins |
| 01/27/2000 | WO2000004176A1 Process to collect metabolites from modified nectar by insects |
| 01/27/2000 | WO2000004175A1 Methods and composition for modulating flavonoid content |
| 01/27/2000 | WO2000004174A1 Recombination repair gene, mim, from arabidopsis thaliana |
| 01/27/2000 | WO2000004173A1 Methods and means to modulate programmed cell death in eukaryotic cells |
| 01/27/2000 | WO2000004172A1 Method of making proteins in transformed yeast cells |
| 01/27/2000 | WO2000004171A1 Treatment of diabetes with synthetic beta cells |
| 01/27/2000 | WO2000004170A1 Cleavage of caulobacter produced recombinant fusion proteins |
| 01/27/2000 | WO2000004169A1 New caspase homologue |
| 01/27/2000 | WO2000004168A1 Ornithine biosynthesis enzymes |
| 01/27/2000 | WO2000004167A2 Genes encoding sulfate assimilation proteins |
| 01/27/2000 | WO2000004166A2 Plant cellulose synthases |
| 01/27/2000 | WO2000004165A1 Genes encoding sulfate assimilation proteins |
| 01/27/2000 | WO2000004164A2 Glucosylglycerol phosphate synthase gene for producing the low-molecular protective substance glucosylglycerol and the use thereof |
| 01/27/2000 | WO2000004163A1 Tetrahydrofolate metabolism enzymes |
| 01/27/2000 | WO2000004162A2 Genes encoding sulfate assimilation proteins |
| 01/27/2000 | WO2000004161A1 Genes encoding sulfate assimilation proteins |
| 01/27/2000 | WO2000004160A1 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 01/27/2000 | WO2000004159A1 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 01/27/2000 | WO2000004158A2 Compositions and methods for fumonisin detoxification |
| 01/27/2000 | WO2000004157A2 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | WO2000004156A2 SEROTYPE-SPECIFIC PROBES FOR $i(LISTERIA MONOCYTOGENES) |
| 01/27/2000 | WO2000004155A2 Compositions and methods for enhancing disease resistance in plants |
| 01/27/2000 | WO2000004154A2 Genes encoding sulfate assimilation proteins |
| 01/27/2000 | WO2000004153A2 Repression of cell transformation with human pea3 |
| 01/27/2000 | WO2000004152A2 Androgen receptor coactivators |
| 01/27/2000 | WO2000004151A2 Identification and characterization of splice variants of kappa3-related opioid receptor (kor3) gene |
| 01/27/2000 | WO2000004150A1 Human presenilin-associated protein |
| 01/27/2000 | WO2000004149A2 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | WO2000004148A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia |
| 01/27/2000 | WO2000004147A1 Differentiation regulatory factor expressed specifically in testis |
| 01/27/2000 | WO2000004146A1 A synthetic polynucleotide coding for human lactoferrin, vectors, cells and transgenic plants containing it |
| 01/27/2000 | WO2000004145A2 Myotilin, an actin-organizing protein |
| 01/27/2000 | WO2000004144A1 Snurpotine i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | WO2000004143A1 Mammalian fast transcription factor |
| 01/27/2000 | WO2000004142A1 Mucins |
| 01/27/2000 | WO2000004141A2 Use of nucleic acid molecules as antiviral agents |
| 01/27/2000 | WO2000004140A1 71 human secreted proteins |
| 01/27/2000 | WO2000004139A1 Micellar systems |
| 01/27/2000 | WO2000004137A1 Human aspartic proteases |
| 01/27/2000 | WO2000004136A1 Glucoamylase variants |
| 01/27/2000 | WO2000004134A1 Novel gene and transformant carrying the same |
| 01/27/2000 | WO2000004133A1 Agrobacterium-mediated transformation of turfgrass |
| 01/27/2000 | WO2000004052A2 Soluble derivatives of anti-angiogenic peptides |
| 01/27/2000 | WO2000004051A2 Growth differentiation factor promoter and uses therefor |
| 01/27/2000 | WO2000004050A2 Neurotrophic growth factor |
| 01/27/2000 | WO2000004049A1 Chimeric polypeptides allowing expression of plant-noxious proteins |
| 01/27/2000 | WO2000004048A1 Peptides of il-2 and derivatives thereof and their use as therapeutic agents |
| 01/27/2000 | WO2000004045A1 Axor10, a g-protein coupled receptor |
| 01/27/2000 | WO2000004043A1 Protease susceptibility ii |
| 01/27/2000 | WO2000004041A2 Methods and molecules relating to cd39-like polypeptides |
| 01/27/2000 | WO2000004040A2 Constitutive disease resistance gene (cdr1), and methods of use thereof |
| 01/27/2000 | WO2000004031A1 Phosphorous organic compounds and their use |
| 01/27/2000 | WO2000003738A1 Chelating systems for use in the delivery of compounds to cells |
| 01/27/2000 | WO2000003726A1 Lysine binding fragments of angiostatin |
| 01/27/2000 | WO2000003720A1 Carbohydrate or 2'-modified oligonucleotides having alternating internucleoside linkages |
| 01/27/2000 | WO2000003699A2 Drugs containing phosphoric acid derivatives as active ingredient and their use |
| 01/27/2000 | WO2000003694A1 Charge reversal of polyion complexes |
| 01/27/2000 | WO2000003687A2 Potassium channel polypeptide and polynucleotide compositions |
| 01/27/2000 | WO2000003683A2 Liposomal encapsulated nucleic acid-complexes |
| 01/27/2000 | WO2000003581A1 Process for preparing clavam derivatives by using polypeptides having beta-lactam synthetase activity |
| 01/27/2000 | WO1999066026A3 Methods and means for expression of mammalian polypeptides in monocotyledonous plants |
| 01/27/2000 | WO1999064604A3 Attenuated pestiviruses |
| 01/27/2000 | WO1999063938A3 Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs |
| 01/27/2000 | WO1999063115A3 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 01/27/2000 | WO1999063096A3 Acyl coa:cholesterol acyltransferase related nucleic acid sequences |
| 01/27/2000 | WO1999063086A3 Insulin-like growth factor binding protein-3 variants |
| 01/27/2000 | WO1999063081A3 Ion channels |
| 01/27/2000 | WO1999061665A3 Solution hybridization of nucleic acids with antisense probes having modified backbones |
| 01/27/2000 | WO1999061640A3 Aav derived vector |
| 01/27/2000 | WO1999061639A3 Retroviral delivery system |